# US 2025/0375538 A1 · COMPOSITIONS AND METHODS FOR IMPROVED mRNA PRODUCTION

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0375538 A1
- Document ID: US20250375538A1
- Status: Published application
- Kind: A1
- Application number: 19/227,388
- Filed: 2025-06-03
- Published: 2025-12-11
- Earliest claimed: 2024-06-05
- Assignees: The Hong Kong University of Science and Technology
- Applicants: The Hong Kong University of Science and Technology
- Inventors: Yi KUANG; Cheuk Yin LI; Lala FU
- Web page: https://patentgrep.com/patent/US20250375538A1

## CPC

- A61K 48/0066: {Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid}
- C12N 15/85: for animal cells
- C12N 2830/50: regulating RNA stability, not being an intron, e.g. poly A signal
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention discloses a modified poly(A) sequence for use in a recombinantly produced mRNA molecule for the purpose of improving the production process of the mRNA and subsequent protein expression from the mRNA. Thus, new and effective compositions and methods are provided for use in various applications involving improved production process of an mRNA of interest as well as enhanced expression of the mRNA-encoded protein.

## Claims

### Claim 1

An artificial poly(A) sequence having about 20-60 adenines at its 5′ end, about 5-20 random nucleotides, about 30-90 adenines, about 5-40 cytosines, and 1-5 adenines at its 3′ end.

### Claim 2 (depends on 1)

The artificial poly(A) sequence of claim 1, wherein the number of cytosines is no more than ⅓ of the total number of nucleotides of the artificial poly(A) sequence.

### Claim 3 (depends on 1)

The artificial poly(A) sequence of claim 1, having about 25-50 adenines at its 5′ end, about 7-15 random nucleotides, about 40-80 adenines, about 7-20 cytosines, and 1-3 adenines at its 3′ end.

### Claim 4 (depends on 1)

The artificial poly(A) sequence of claim 1, having about 30 adenines at its 5′ end, about 10 random nucleotides, about 60 adenines, and about 10 cytosines in between 1 adenine at its 3′ end.

### Claim 5 (depends on 1)

The artificial poly(A) sequence of claim 1, having 30 adenines, 10 random nucleotides, 59 adenines, 10 cytosines, and 1 adenine from its 5′ end to its 3′ end.

### Claim 6 (depends on 1)

The artificial poly(A) sequence of claim 1, having the nucleotide sequence set forth in SEQ ID NO:4.

### Claim 7 (depends on 1)

The artificial poly(A) sequence of claim 1, which is a DNA sequence.

### Claim 8 (depends on 1)

The artificial poly(A) sequence of claim 1, which is an RNA sequence.

### Claim 9 (depends on 1)

An expression cassette comprising a promoter and a polynucleotide sequence encoding the artificial poly(A) sequence of claim 1.

### Claim 10 (depends on 9)

The expression cassette of claim 9, further comprising a multiple cloning site between the promoter and the polynucleotide sequence encoding the artificial poly(A) sequence.

### Claim 11 (depends on 9)

The expression cassette of claim 9, further comprising a transcription initiation codon and a transcription termination codon, both operably linked to the promoter and the polynucleotide sequence encoding the artificial poly(A) sequence.

### Claim 12 (depends on 9)

The expression cassette of claim 9, further comprising a polynucleotide sequence encoding one or more polypeptides between the promoter and the artificial poly(A) sequence, wherein the polynucleotide sequence is operably linked to the promoter and the polynucleotide sequence encoding the artificial poly(A) sequence.

### Claim 13 (depends on 9)

The expression cassette of claim 9, wherein the artificial poly(A) sequence is set forth in SEQ ID NO:4.

### Claim 14 (depends on 9)

A vector comprising the expression cassette of claim 9.

### Claim 15 (depends on 9)

A host cell comprising the expression cassette of claim 9.

### Claim 16 (depends on 9)

A composition comprising the expression cassette of claim 9.

### Claim 17 (depends on 9)

An RNA transcribed from the expression cassette of claim 9.

### Claim 18 (depends on 1)

An RNA comprising a coding sequence for one or more polypeptides and the artificial poly(A) sequence of claim 1.

### Claim 19 (depends on 17)

The RNA of claim 17, wherein the artificial poly(A) sequence is set forth in SEQ ID NO:4.

### Claim 20 (depends on 17)

A composition comprising the RNA of claim 17.

### Claim 21 (depends on 20)

The composition of claim 20, further comprising an adjuvant.

### Claim 22 (depends on 9)

A method for RNA transcription in a cell or a cell lysate, comprising (i) transfecting the cell with the expression cassette of claim 9; and (ii) cultivating the cell or maintaining the lysate under conditions permissible for RNA transcription from the expression cassette.

### Claim 23 (depends on 22)

The method of claim 22, further comprising isolating the RNA transcribed in step (ii).

### Claim 24 (depends on 22)

The method of claim 22, wherein the cell is a bacterial cell or the cell lysate is a bacterial cell lysate.

### Claim 25 (depends on 9)

A method for recombinant protein expression in a cell, comprising (i) transfecting the cell with the expression cassette of claim 9; and (ii) cultivating or maintaining the cell under conditions permissible for protein expression from the expression cassette.

### Claim 26 (depends on 22)

The method of claim 22, wherein the artificial poly(A) sequence is set forth in SEQ ID NO:4.

### Claim 27 (depends on 22)

The method of claim 22, wherein the cell is within a human body.
